Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

DARPA Pandemic Prevention Platform (P3) Proposers Day Events

by Global Biodefense Staff
February 7, 2017
DARPA Biotechnologies Office

The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) is sponsoring two Proposers Day events in support of the Pandemic Prevention Platform (P3) program.

A Proposers Day will be held on February 22, 2017 in McLean, VA and another on March 2, 2017 in San Diego, CA.

The events aim to introduce the science and technology community to the P3 program vision and goals; facilitate interaction between investigators that may have capabilities to develop elements of interest and relevance to P3; and to encourage and promote teaming arrangements among organizations that have the relevant expertise or research facilities.

The goal of P3 is to achieve an integrated capability that can deliver pandemic prevention countermeasures to patients within 60 days of an outbreak. P3 aims to revolutionize outbreak response by enabling rapid discovery, characterization, production, and testing of efficacious medical countermeasures.

P3 will innovate in the following thrust areas:

  • Generation of virus stock (including viral unknowns)
  • Rapid evolution of antibody candidates
  • Gene-encoded antibody delivery methods

Attendance at this event is not a requirement for submission of a proposal or selection for funding. Information relayed during the Proposers Day will be made available on the BTO section of the DARPA Opportunities Page.

Advance registration is required. All attendees are required to present government-issued photo identification upon entry to the event. Non-US citizens are required to submit a DARPA Form 60 “Foreign National Visit Request,” which is available on the registration website.

Further details about the P3 program are available via Solicitation Number: HR001117S0019. The Broad Agency Announcement proposal abstract submission deadline is March 13, 2017 by 12:00 pm ET.

Tags: DARPAPandemic

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC